Ucsd Radiation Oncology is categorized under Oncologists in Chula Vista, CA and active since 2009.
Ucsd Radiation Oncology was established in 2009, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Teresa Langley, Manager at the company’s single location by writing to 959 Lane Avenue, Chula Vista, California CA 91914 or by phoning (619) 502-7730. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ucsd Radiation Oncology |
| Contact Person: | Teresa Langley, Manager |
| Address: | 959 Lane Avenue, Chula Vista, California 91914 |
| Phone Number: | (619) 502-7730 |
| Website Address: | ucsd.edu |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Ucsd Radiation Oncology was started in 2009 to provide professional Oncologists under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Teresa Langley, Manager for inquiries that concern Ucsd Radiation Oncology by calling the company number (619) 502-7730, as your correspondence is most welcome. Additionally, the physical location of the single location of Ucsd Radiation Oncology can be found at the coordinates 32.65075,-116.96144 as well as the street address 959 Lane Avenue in Chula Vista, California 91914.
For its online presence, you may visit Ucsd Radiation Oncology’s website at ucsd.edu and engage with its social media outlets through on Twitter and on Facebook.